UBE2U,or "Ubiquitin-Conjugating Enzyme E2 U," is a protein that in humans is encoded by the UBE2U gene. This enzyme is a member of the ubiquitin-conjugating (E2) enzyme family, playing a crucial role in the ubiquitination pathway, a fundamental process for protein degradation and regulation within the cell.Ubiquitination is a process where ubiquitin, a small regulatory protein, is attached to substrates, typically signaling them for degradation via the proteasome or altering their cellular location, activity, or interactions. UBE2U functions as an E2 enzyme, which is responsible for the transfer of ubiquitin from the E1 activating enzyme to specific substrates, often with the assistance of an E3 ubiquitin ligase.The specific substrates and biological functions of UBE2U are still under research, but given the general importance of ubiquitination in cellular regulation, it is likely involved in multiple critical cellular processes. This can include cell cycle regulation, DNA repair, and response to stress or external stimuli.
UBE2U's role in ubiquitination suggests its involvement in various disease pathways, particularly those where protein degradation and regulation are disrupted, such as in cancer, neurodegenerative disorders, and inflammatory conditions. Abnormalities in ubiquitination processes are linked to the pathogenesis of these diseases, highlighting the significance of enzymes like UBE2U in maintaining cellular homeostasis.In summary, UBE2U is an important component of the ubiquitination pathway, with roles in various cellular processes and disease mechanisms. As such, it remains a subject of active research in the field of molecular biology and biochemistry.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Le MG132, un inhibiteur du protéasome, peut affecter les voies ubiquitine-protéasome, ce qui pourrait avoir un impact sur la fonction de l'UBE2U. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Un autre inhibiteur du protéasome, le bortézomib, pourrait influencer indirectement l'UBE2U en affectant les voies de dégradation des protéines. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Lactacystine, un inhibiteur spécifique du protéasome, peut moduler les processus d'ubiquitination, affectant potentiellement l'UBE2U. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Inhibiteur de l'enzyme activatrice d'ubiquitine E1, PYR-41 pourrait avoir un impact indirect sur l'activité de l'UBE2U dans la voie d'ubiquitination. | ||||||
DBeQ | 177355-84-9 | sc-499943 | 10 mg | $330.00 | 1 | |
Inhibe l'USP14, une enzyme de déubiquitination, influençant potentiellement les voies d'ubiquitination impliquant l'UBE2U. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Modifie les voies de dégradation des protéines, pourrait avoir des effets indirects sur l'activité de l'UBE2U. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $49.00 $367.00 $2030.00 | 18 | |
Médicament immunomodulateur, peut influencer l'homéostasie des protéines et potentiellement la fonction de l'UBE2U. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $98.00 $140.00 $306.00 $459.00 $1224.00 $1958.00 | 1 | |
Similaire à la thalidomide, affecte les voies de dégradation des protéines, ayant un impact potentiel sur l'UBE2U. | ||||||